- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Prostatic Neoplasms
Medical specialists from France tagged as investigators in clinical trials studying Prostatic Neoplasms
Total 332 results
-
patrick-julien treacySeen in:
- Cannes, Cannes Hospital
Trials:- NCT03947515 (Principal Investigator)
Conditions: -
Paul SARGOSSeen in:
- Bordeau, Institut Bergonié
- Bordeaux, Institut Bergonié
Trials:- NCT04181203 (Principal Investigator)
- NCT03830788 (Principal Investigator)
Conditions: -
Philippe BARTHELEMY, MDSeen in:
- Bas Rhin, Strasbourg, Institut de cancérologie Strasbourg Europe (ICANS)
- Strasbourg, Institut de cancerologie Strasbourg Europe
Trials:- NCT05551117 (Principal Investigator)
- NCT06379880 (Principal Investigator)
Conditions:- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Independent Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Anal Neoplasm;
- Breast Neoplasms;
- Lung Neoplasms;
- Prostatic Neoplasms;
- Colorectal Neoplasms
-
PHILIPPE LAPLAIGESeen in:
- Centre, La Chaussée-Saint-Victor, Polyclinique De Blois
- La Chaussee Saint Victor, Polyclinique De Blois
Trials:- NCT04975308 (Principal Investigator)
- NCT05288166 (Principal Investigator)
- NCT05514054 (Principal Investigator)
Conditions:- Breast Neoplasms;
- Neoplasm Metastasis;
- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Philippe MAINGONSeen in:
- Paris, Groupe Hospitalier Pitie-Salpetriere
Trials:- NCT03438552 (Principal Investigator)
Conditions: -
Philippe Robin, PHSeen in:
- Brest, CHRU de Brest
Trials:- NCT04745871 (Principal Investigator)
Conditions: -
Pierre AUBERDIACSeen in:
- Albi, Clinique Claude Bernard
Trials:- NCT04181203 (Principal Investigator)
Conditions: -
Pierre Blanchard, MDSeen in:
- Cedex, Villejuif, Institut Gustave Roussy
- Villejuif, Gustave Roussy
Trials:- NCT03830788 (Principal Investigator)
- NCT04905069 (Principal Investigator)
Conditions: -
Pierre COLIN, MDSeen in:
- Amiens, Amiens university hospital
- Lille, Hôpital Privé La Louvière
- Lille, Service d'Urologie Générale de Santé - Hôpital Privé La Louvière
Trials:- NCT05710861 (Principal Investigator)
- NCT05415631 (Principal Investigator)
- NCT03568188 (Principal Investigator)
- NCT03531099 (Principal Investigator)
Conditions: -
Pierre CONORT, MD, PhDSeen in:
- Paris, Groupe Hospitalier Pitié Salpétrière
Trials:- NCT04773821 (Principal Investigator)
Conditions: -
Pierre CORNILLON, MDSeen in:
- Saint-Priest-en-Jarez, CHU de Saint-Etienne
- Saint-Étienne, CHU Saint-Etienne - Oncologie
Trials:- NCT05739565 (Principal Investigator)
- NCT06379880 (Principal Investigator)
-
Pierre DALLOZ, MDSeen in:
- Clermont-Ferrand, Pole Santé République
Trials:- NCT06379880 (Principal Investigator)
Conditions: -
Pierre Fenaux, MDSeen in:
- Paris, Hopital St Louis
Trials:- NCT02649790 (Principal Investigator)
- NCT02473146 (Principal Investigator)
-
Pierre Graff-Cailleaud, MDSeen in:
- Toulouse, IUCT
- Toulouse, Institut Claudius Regaud
Trials:- NCT03830788 (Principal Investigator)
- NCT04299646 (Principal Investigator)
Conditions: -
Pierre MOZER, MDSeen in:
- Paris, Department of radiology and urology, Hôpital la Pitié Salpêtrière
- Paris, Hôpital de la Pitié-Salpêtrière (Assistance Publique - Hôpitaux de Paris)
Trials:- NCT04582656 (Principal Investigator)
- NCT04732156 (Sub-Investigator)
Conditions: -
Pierre OLIVIER, MD,PhDSeen in:
- Nancy, Central Hospital Nancy
- Vandoeuvre Les Nancy, CHRU de NANCY- BRABOIS
Trials:- NCT03623425 (Principal Investigator)
- NCT03344822 (Sub-Investigator)
Conditions: -
Pierre Thierry PIECHAUD, MDSeen in:
- Bordeaux, Clinique de Saint Augustin
Trials:- NCT04638088 (Principal Investigator)
Conditions: -
Pierre-Henri SAVOIESeen in:
- Toulon, HIA Sainte Anne
Trials:- NCT03088124 (Principal Investigator)
Conditions: -
Pierre-Thierry PIECHAUD, MDSeen in:
- Bordeaux, Clinique St Augustin
Trials:- NCT05763355 (Principal Investigator)
Conditions: -
Pierre-Yves Le Roux, PU-PHSeen in:
- Brest, CHRU de Brest
Trials:- NCT04745871 (Sub-Investigator)
Conditions: -
Pierre-Yves Salaun, PU-PHSeen in:
- Brest, CHRU de Brest
Trials:- NCT04745871 (Sub-Investigator)
Conditions: -
Quentin Come LE CLERC, MDSeen in:
- Nantes, Clinique Saint-Augustin
Trials:- NCT04638088 (Principal Investigator)
Conditions: -
Rafael SANCHEZ SALAS, MD, PhDSeen in:
- Paris, Département d'Urologie, Institut Montsouris
Trials:- NCT03568188 (Principal Investigator)
Conditions: -
Rafael SANCHEZ-SALAS, DrSeen in:
- Paris, Institut Mutualiste Montsouris
Trials:- NCT03088124 (Sub-Investigator)
Conditions: -
Raffaele RattaSeen in:
- Ile De France, Suresnes, Hopital Foch
- Suresnes, Hopital Foch
Trials:- NCT05848011 (Principal Investigator)
- NCT05551117 (Principal Investigator)
Conditions:- Prostate Cancer Recurrent;
- Immunotherapy;
- Androgen-Independent Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Immune Checkpoint Inhibitor;
- Androgen-Independent Prostatic Neoplasms;
- Androgen-Insensitive Prostatic Cance;
- Inhibitory Checkpoint Molecule;
- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Anal Neoplasm
Clinical Trials on Prostatic Neoplasms
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaRecruitingCastration Resistant Prostatic CancerAustralia
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer
-
Institut Claudius RegaudWithdrawnProstatic Cancer, Castration-ResistantFrance
-
Technische Universität DresdenRecruitingOligometastatic Disease | Prostatic Cancer, Castration-ResistantGermany
-
Rio de Janeiro State UniversityCompletedProstatic Cancer | Prostatic NeoplasmBrazil
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
University Hospital, GrenobleTerminatedCastration-resistant Prostate CancerFrance
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingProstatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic NeoplasmsUnited States, Canada